Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantation. Leuk Res 2021 Oct;109:106648
Date
06/29/2021Pubmed ID
34182226DOI
10.1016/j.leukres.2021.106648Scopus ID
2-s2.0-85109506946 (requires institutional sign-in at Scopus site)Author List
Mohan M, Hari P, Szabo A, Dhakal B, Chhabra S, D'Souza AAuthors
Anita D'Souza MD Associate Professor in the Medicine department at Medical College of WisconsinBinod Dhakal MD Associate Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Aniko Szabo PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AgedAntibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Combined Modality Therapy
Consolidation Chemotherapy
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Multiple Myeloma
Prognosis
Survival Rate
Transplantation, Autologous